A number of studies suggest that weight-bearing exercises have beneficial effects on bone and increases in BMD of the skeleton. In Hungary 900,000 people suffer from OP, there are 30,000 vertebral fractures, 51,000 other fractures in a year. The aim of this study was to measure if there is any direct, detected effect of one specific physiotherapy programme on biomechanical markers of bone metabolism. METHODS: Total of 50 young, healthy adults (age 25Ϯ2) were included without any disease or condition of the calcium and bone metabolism (using laboratory tests and Quantitative Ultrasound). Fifteen men and 15 women carried out specific exercises during 60 min, directed by physiotherapist; and 20 women performed 60 min steady walking in the same time. At the beginning and in the end of training programs laboratory tests were carried out to measure the level of bonespecific alkaline phosphate (BALP) and ␤-cross-laps value. Data were analysed by Wilcoxon tests applying SPSS statistic programme. RESULTS: In both groups a slight, statistically not significant decrease was detected in the value of BALP (pϭ0.322 vs. pϭ 0.219; rate of decrease in the target group 3.67%, in control group: 7.16%). Significant decrease was detected in the ␤-cross laps-values in all groups. In the target group the value of ␤-cross laps decreased with 23.13% (pϭ0.0066), in the control group with 53.2% (pϭ0.0008). No relationship was found between smoking, rheumatic diseases run in the family and BMD, but a medium relationship between regular exercise and BMD could be detected (rϭ0.4392). CONCLUSIONS: This study proved that the 60-minute, middle intensity, appropriate physiotherapy (even onetime) has an immediate effect on BALP level, in contrary ␤-cross-laps scores decrease significantly measured immediately after the training. So bone loss and at the same time bone formation started due to mechanical overload.
PMS6 A NETWORK META-ANALYSIS OF BIOLOGIC TREATMENTS IN TNF-IR RHEUMATOID ARTHRITIS PATIENTS
LeReun C 1 , Neophytou I 2 , De Vries R 3 , Diamantopoulos A 2 , Pompen M 4 1 Independent Biostatistician, Carrigaline county, Cork, Ireland, 2 Symmetron Limited, Elstree, Herts, UK, 3 Roche, Woerden, Woerden, The Netherlands, 4 Roche, Woerden, Woerden, The Netherlands OBJECTIVES: Following the introduction of biologic DMARDs, clinicians have now a multitude of options for the treatment of RA patients with inadequate response to anti-TNF␣. This study considers evidence on ACR response from randomised controlled trials of biologic treatments and employs a network meta-analysis to identify differences amongst them. METHODS: The study considers evidence for the following treatments: abatacept, anti-TNF␣, rituximab, and tocilizumab. Pivotal studies were reviewed and ACR response was extracted for each of the above treatments. A network meta-analysis using a Bayesian approach was implemented in WinBUGS®. Fixed-effects and random effects models were explored. Initially, the development of the study considered all anti-TNF␣ treatments separately. However, there was limited evidence on ACR response for all of them in the specified patient subgroup (TNF-IR). This was considered an important factor for treatment efficacy since studies performed on DMARD-IR or MTX-IR population would include a subgroup of patients with less severe disease. A class effect was assumed for all anti-TNF␣ and ACR response from Smolen et. al (2009) was assumed to represent treatment efficacy of all anti-TNFs. RESULTS: For the base-case analysis, the result shows tocilizumab to have a significant benefit on ACR 20 response of patients. In ACR 50 all biologics have a similar profile. Rituximab becomes the most efficacious treatment in ACR 70. CONCLUSIONS: The study demonstrates that assuming an indirect comparison of biologics based on a network analysis, tocilizumab has better profile than the other biologics in ACR 20 and ACR 50 while rituximab is better in ACR 70. Further research is needed to produce evidence on ACR response for all treatments in TNF-IR population. 807, 808, 810, 811, 812, 821, 823, 733.10, 733.11, 733.15, 733.16, 733.19) were identified and included in the study. Frequencies and incidences of each fracture by age were estimated, and the 4-year incidence trend was further evaluated. RESULTS: A total of 65,118 hip fractures, the most serious osteoporosis outcome, occurred during the study period and the incidence is increasing by 3-6% per year. We found a high annual incidence rate of clinical vertebral fracture in 4 consecutive years in Taiwan. The average rate was 1.43%, 1.51%, 1.59%, and 1.63% respectively. In addition, Wrist fracture and other fracture all increased slightly. Each type of fractures showed a steady increase in the age-adjusted incidence. CONCLUSIONS: The age-specific incidence rates of hip fractures and vertebral fractures were higher with increasing age, especially after 60 years of age. Compared with other countries, Elderly Taiwanese women also have a high incidence rate of hip and vertebral fracture. Our results clearly demonstrated that the effect of osteoporosis and osteoporotic fracture in Taiwan. We should take more active public health strategies in the rapidly aging society. OBJECTIVES: Low bone mineral density (BMD) is one of several important clinical risk factors (CRFs) for fractures. However, frequency distributions of individual and multiple CRFs have not been extensively reported. The study aim was to quantify the CRF profile in a Canadian population. METHODS: Data on CRFs were obtained from the Canadian Multicentre Osteoporosis Study (CaMos) database, a prospective and longitudinal cohort study following subjects for over10 years. Subjects with femoral neck BMD T-scores Ͻ Ϫ1.0 were selected and grouped as osteopenia (Ϫ1.0 Ͻ T-scoreϽϪ2.5), osteoporosis [OP] (T-score Ͻ Ϫ2.5), very-low BMD [VLBMD] (Ϫ3.5 Ͻ T-score ϽϪ2.5), and extremely-low BMD [ELBMD] (T-score Ͻ Ϫ3.5). Frequencies of other CRFs (prevalent fracture, rheumatoid arthritis, glucocorticoid use, parental hip fracture, smoking status, alcohol consumption, recent falls) were estimated for BMD T-scores, by age and sex. RESULTS: Among low-BMD women, 2716 (85%) had osteopenia, 491 (15%) had OP; 460 and 31 had VLBMD and ELBMD, respectively. There were 635 low-BMD men (602, 33, 30, and 3 with osteopenia, OP, VLBMD, and ELBMD, respectively). OP prevalence increased by age in women (men): Ͻ4% (9%) in age 50-59 to 43% (44%) in age 70-79. In OP women, 21% had 1 previous fracture; 10% had 2ϩ. Corresponding values for ELBMD women were 32% and 52%, respectively. The distribution of multiple CRFs among OP women was: 35%, 43%, 17%, 4%, and 1% for 0-4 additional CRFs. None had over four. In OP women with prevalent fracture, the distribution was 65%, 29%, 6%, and 1% for 1-4 additional CRFs. CONCLUSIONS: Among the low-BMD population in CaMos, 15% of women and 5% of men had OP, and over 30% also had prevalent fracture. Over 50% with OP and prevalent fracture also had at least one additional CRF. These data may inform estimates on potential fracture incidence and burden in the population. 
PMS7 THE OSTEOPOROTIC FRACTURE INCIDENCE IN ELDERLY WOMEN OF TAIWAN

PMS8 PREVALENCE OF CLINICAL RISK FACTORS FOR FRACTURES IN THE CANADIAN MULTICENTRE OSTEOPOROSIS STUDY
PMS9
PREVALENCE OF SHOULDER OSTEOARTHISTIS AND TREATMENT IN A LARGE US MANAGED CARE POPULATION
OBJECTIVES:
To estimate the prevalence of shoulder osteoarthritis (OA) and its treatments. METHODS: Data from Thomson MarketScan (2005) (2006) (2007) (2008) , a large national managed care population database representing more than 500 million employer-based medical and pharmacy claims were analyzed. Annual prevalence was calculated as the number of continuously eligible patients who had at least one shoulder OA diagnosis divided by the total number of continuously eligible patients. Treatment prevalence was assessed for inpatient shoulder surgery, steroid injections, physical therapy and pain medication and was calculated as the number of patients receiving these treatment divided by the number of patients with a shoulder OA diagnosis. Prevalence percentages were presented descriptively by age group and overall. RESULTS: There were approximately 20 to 26 million continuously eligible patients in the data annually between 2005 and 2008. The overall prevalence of patients with at least one shoulder OA diagnosis was relatively stable over the years and ranged from 1.1 to 1.2%. In 2008, the shoulder OA prevalence by age group was: 0 to Ͻ18 -0.01%; 18 to Ͻ40 -0.21%; 40 to Ͻ65 -1.55%; and 65 and greater -4.16%. Shoulder surgery was most prevalent in the 40 to Ͻ65 age group (ϳ1%), with around 2% prevalence in the 65 and greater age group. Physical therapy was most common in the Ͻ65 year old groups (16.2% to 14.8%), while 65 and older age group had around 8% prevalence. Steroid injections occurred in ϳ10% of the patients who were 18 or greater. Use of pain medications increased with age and ranged by age group from ϳ 5% to 36%. CONCLUSIONS: The prevalence of a shoulder OA diagnosis was approximately 1.1%, with patients Ͼ65 age having the highest prevalence (Ͼ4%). Shoulder OA treatment related resource utilization showed significant use of drug therapy, physical therapy, and steroid use.
PMS10 EVALUATION THE RISK FACTORS OF SECOND HIP FRACTURES IN THE ELDERLY
Sebestyén A 1 , Sándor J 2 , Patzai B 3 , Gõcze K 3 , Kriszbacher I 3 , Mintál T 3 , Boncz I 3 1 South-Trasdanubian Regional Health Insurance Fund Administration, Pécs, Hungary, 2 University of Debrecen, Debrecen, Hungary, 3 University of Pécs, Pécs, Hungary OBJECTIVES: The aim of the study is to evaluate the risk factors of second hip and femur fractures in patients aged over 60 years after initial hip fractures. METHODS: In this retrospective study the data derive from the financial database of the Hungarian National Health Insurance Fund Administration. The study includes patients over 60 years following primary treatment of femoral neck fracture (S7200) discharged from inpatient care institutions in 2000. Fractures that happened in hospitals were excluded from the analysis. The follow up period was 8 years. We evaluated data according to sex, age group, type of living place, type of hospital treated the primary fracture, type of primary femoral neck fracture, absence or presence of comorbidities, type of surgical intervention for primary fracture, and antiosteoporotic pharmacologic treatment after primary fracture. The effects of prognostic factors were evaluated by Cox proportional hazard regression analysis (HR, 95 % CI, p). RESULTS: Altogether 3638 patients were included into the study. 
